News
- Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic DermatitisDecember 22, 2020 8:31 AM EST
- Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel DiseaseDecember 21, 2020 8:31 AM EST
- Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal AntibodyDecember 11, 2020 8:00 AM EST
Events
- Monday, December 7, 2020 10:00 AM EST
- Thursday, November 19, 2020
- Tuesday, November 17, 2020 from 2:40 PM to 3:10 PM EST
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Event Details
Kindred Biosciences' First Quarter 2020 Financial Results
Webcast Presentation